Plasma and Cerebro Spinal Fluid Amyloid Beta 42, 40 and the 42:40 ratio for diagnosis of incipient Dementia in a population with objective cognitive declinePlasma and CSF Abeta for the longitudinal prediction of Alzheimer's disease dementia and other dementias in people with cognitive decline but no dementiaPlasma and Cerebro Spinal Fluid Amyloid Beta 42, 40 and the 42:40 ratio for diagnosis of incipient Dementia in a population with objective cognitive declineIron-export ferroxidase activity of β-amyloid precursor protein is inhibited by zinc in Alzheimer's diseaseNeuronal sorting protein-related receptor sorLA/LR11 regulates processing of the amyloid precursor protein.Homo- and heterodimerization of APP family members promotes intercellular adhesion.MR-less surface-based amyloid assessment based on 11C PiB PETMetals and amyloid-beta in Alzheimer's diseaseStabilization of neurotoxic soluble beta-sheet-rich conformations of the Alzheimer's disease amyloid-beta peptideGenetic heterogeneity in Alzheimer disease and implications for treatment strategiesEnduring Elevations of Hippocampal Amyloid Precursor Protein and Iron Are Features of β-Amyloid Toxicity and Are Mediated by TauStructure of the Alzheimer's disease amyloid precursor protein copper binding domain. A regulator of neuronal copper homeostasisStructural studies of the Alzheimer's amyloid precursor protein copper-binding domain reveal how it binds copper ionsAmyloid-beta-anti-amyloid-beta complex structure reveals an extended conformation in the immunodominant B-cell epitopeCrystal structure of the amyloid-β p3 fragment provides a model for oligomer formation in Alzheimer's diseaseStructural studies of the tethered N-terminus of the Alzheimer's disease amyloid-β peptideApolipoprotein D levels are elevated in prefrontal cortex of subjects with Alzheimer's disease: no relation to apolipoprotein E expression or genotypeEvidence for a copper-binding superfamily of the amyloid precursor proteinA primer of amyloid nomenclatureThe proteolytic processing of the amyloid precursor protein gene family members APLP-1 and APLP-2 involves alpha-, beta-, gamma-, and epsilon-like cleavages: modulation of APLP-1 processing by n-glycosylationTau imaging: early progress and future directionsQuantitative Amyloid Imaging in Autosomal Dominant Alzheimer's Disease: Results from the DIAN Study GroupAdvancing Alzheimer's disease diagnosis, treatment, and care: recommendations from the Ware Invitational SummitDeveloping an international network for Alzheimer research: The Dominantly Inherited Alzheimer NetworkAssociation of plasma Aß peptides with blood pressure in the elderlyClinical and biomarker changes in dominantly inherited Alzheimer's disease.Neurological manifestations of autosomal dominant familial Alzheimer's disease: a comparison of the published literature with the Dominantly Inherited Alzheimer Network observational study (DIAN-OBS).Intracellular amyloid formation in muscle cells of Abeta-transgenic Caenorhabditis elegans: determinants and physiological role in copper detoxification.Copper promotes the trafficking of the amyloid precursor proteinRegional variability of imaging biomarkers in autosomal dominant Alzheimer's diseaseAmong vitamin B12 deficient older people, high folate levels are associated with worse cognitive function: combined data from three cohorts.Cytosolic beta-amyloid deposition and supranuclear cataracts in lenses from people with Alzheimer's disease.Mechanisms of peripheral microvascular dysfunction in transgenic mice overexpressing the Alzheimer's disease amyloid Abeta protein.Molecular mechanisms for Alzheimer's disease: implications for neuroimaging and therapeutics.The amyloid precursor protein (APP) of Alzheimer disease and its paralog, APLP2, modulate the Cu/Zn-Nitric Oxide-catalyzed degradation of glypican-1 heparan sulfate in vivo.Using Robust Normative Data to Investigate the Neuropsychology of Cognitive Aging.Neurotoxic, redox-competent Alzheimer's beta-amyloid is released from lipid membrane by methionine oxidation.Inhibition of gamma-secretase as a therapeutic intervention for Alzheimer's disease: prospects, limitations and strategies.Mitochondrial oxidative stress causes hyperphosphorylation of tau.Dimeric structures of alpha-synuclein bind preferentially to lipid membranes.
P50
Q24234762-25C8999A-9429-4801-B3EA-2020A287EC0EQ24235058-45DED533-8C5D-4D12-BE46-461D2FFF1EDAQ24236736-6CB3F938-86DC-43F2-8B0D-618E082E8F1BQ24298553-F850F447-65F8-4C6D-9A78-80964FA9F438Q24329019-CCB783BC-1105-4969-8F3F-08D05043598BQ24337232-A10793E9-722A-4496-B52B-A98767B5EC91Q24618963-F670AF07-BDB4-4D6B-A731-AB72F0F37E96Q24643555-E0E2EC01-0C17-4A5E-812D-8302D2EABAFBQ24654919-1A792176-2787-4B5A-A0C4-718A2E115123Q26995802-97AD77A8-A84C-4279-8706-77C99F3C9FE9Q27336341-BAA3D356-AD73-4038-A040-F36B1B251658Q27640596-073262BD-9ED7-4691-85B5-7EE8B45270A0Q27643593-0A3924C7-6192-47F4-94A1-D33BBC32C863Q27649747-C2DA9F08-B423-4A84-AF50-D3378D2A4948Q27666598-E99EAC0A-F124-4371-9536-701AACBC3FA7Q27684462-717D29CC-CA72-4097-B82A-3B284975E055Q28188578-6333057F-277A-4C12-8441-E43718866F30Q28215600-D19B6B1C-5E3C-4FC4-9F14-75F927D35804Q28241008-E9B80373-B6FA-44DC-A9EE-AB11491E0832Q28245707-4F0C8AC8-80DD-41C0-814B-C7A05637C859Q28253740-9D383645-39CE-46B7-9EF8-71A554A9A52FQ28550984-A736A769-0FE9-491B-8BC0-AD338EEFCD99Q28709591-A3908963-AC81-4068-94BE-F6A61EE9C0A0Q28714253-8304268A-C286-4FA3-93B2-0FD76958D77BQ28740991-E8647809-7DFD-484A-B499-B8CBF905D61AQ29619940-21B94A87-AB89-4965-97D7-2706A0381591Q30244121-077FE5FA-08AA-4A63-9A3F-1B90596E6977Q30485664-7ACD67FA-A956-474F-BE37-879895E62183Q30498323-30EFE7A6-41DE-4608-B14D-80B02DFD48D3Q30557788-4CA864C2-8767-4B0F-A27D-32C7D6C7BEB4Q30697272-4146CE17-C4D2-4F67-941D-133ABF35B41EQ30725675-727F6C1B-44CD-4ED7-A513-E59AF4CE8A44Q30878835-922FF14C-7AF8-4743-AF16-2B86BEF02343Q31047131-378FFE7A-1E62-4C39-8E42-45C39628A3F4Q31144439-A5B90580-0F14-4C02-9813-685B273951B6Q31147608-B5E7B70F-9C48-49F7-8C71-E254C097A23FQ31154202-6EAB45DF-ACB2-4E91-97E5-22625A254D40Q33243260-ACDA2F1E-FC32-441C-B2AB-BCEB07678537Q33288260-910FE2FC-9574-432E-8628-A939B217E15CQ33318989-30D056E2-5DDB-454A-98B6-5C1D316B99A8
P50
description
Austraalia ülikooli õppejõud
@et
Australian neuropathologist
@en
Australian university teacher
@en-ca
Australian university teacher
@en-gb
australischer Mediziner
@de
hoogleraar uit Australië
@nl
profesor universitar australian
@ro
profesor universitar australian
@sq
profesor universitario australiano
@es
profesor universitario australiano
@gl
name
Colin L. Masters
@ast
Colin L. Masters
@ca
Colin L. Masters
@de
Colin L. Masters
@en
Colin L. Masters
@es
Colin L. Masters
@fr
Colin L. Masters
@ga
Colin L. Masters
@nl
Colin L. Masters
@sl
Colin L. Masters
@sq
type
label
Colin L. Masters
@ast
Colin L. Masters
@ca
Colin L. Masters
@de
Colin L. Masters
@en
Colin L. Masters
@es
Colin L. Masters
@fr
Colin L. Masters
@ga
Colin L. Masters
@nl
Colin L. Masters
@sl
Colin L. Masters
@sq
altLabel
Colin Louis Masters
@en
كولن ماسترز
@ar
prefLabel
Colin L. Masters
@ast
Colin L. Masters
@ca
Colin L. Masters
@de
Colin L. Masters
@en
Colin L. Masters
@es
Colin L. Masters
@fr
Colin L. Masters
@ga
Colin L. Masters
@nl
Colin L. Masters
@sl
Colin L. Masters
@sq
P106
P166
P463
P1006
P214
P244
P269
P1006
P101
P1315
P1412
P166
P19
P21
P213
0000 0001 0800 1161